Earnings Sentiment

Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.

Please consider a small donation if you think this website provides you with relevant information  

    

Sentiment Distribution

   

Earnings Call Transcript Word Cloud

     

Bullish Statements during Earnings call

Statement
This continued dialogue along with our deleveraging activities in 2023 should allow us to capitalize on potential opportunities, which gives us an advantage or less liquid buyers
Have a good year
Our high-quality medical real estate portfolio continues to produce steady results
Our outlook regarding 2024 lease expirations is very good, and in general consistent with our experience on 2023 lease expirations
We continue to closely monitor the ever changing market conditions and are excited about what we see for 2024 and beyond
I am proud of our team for efficiently executing these dispositions during the year
Looking ahead to 2024, I'm excited to see the market for our target acquisitions has improved meaningfully compared to 2023
And so right now our credit facility is a competitive advantage
We believe the strategy of lower leverage growth is prudent in the current environment of sustained higher interest rates, and will lead to long-term growth for our stockholders
We will continue to leverage our competitive advantage, including scale, access to capital and the potential utilization of OP unit deal structures to unlock opportunities
As we begin the year, we are confident that our resilient portfolio and ample liquidity available to us continue to help us navigate these challenging market conditions
Overall, I am pleased with the results of 2023 and want to thank the entire team for their hard work and contributions to our results
We are optimistic about moving forward in our acquisition efforts in 2024 and look forward to sharing our progress with you throughout the year
And we had one last year, and we had -- in 2018 we had a lot of success with that
We are pleased with the results of our dispositions activity in 2023 as we completed three dispositions at a weighted average cap rate of 6.3% that generated $80.5 million of gross proceeds
As acquisition cap rates have risen in response to buyers increased cost of capital, we are seeing sellers begin to adjust their expectations, which is leading to more accretive acquisition opportunities
So through the transaction, we're able to reduce our overall debt and leverage
The beginning in early August, our credit facility pricing improved by 15 basis points as a result of our reduced leverage
And so we were able to eliminate both the administrative burden and reduce that kind of current and prospective kind of cash management issue that we're dealing with there to free up the -- to free up that cash
There's real opportunities for us in the market
So that was really the kind of the element of it that was kind of the successful element of it to reduce debt and leverage from an overall perspective
As we look ahead, we continued our accretive growth strategy while maintaining or lowering our portfolio leverage
So refinancing it through the revolver then frees us up with the ability to have, again, more flexibility relative to those properties
So it's -- each case is unique
In addition, in early August, certain of our forward starting interest rate swaps became effective, replacing maturity swaps, which reduced the interest cost and our $350 million term loan by 30 basis points compared to prior periods
But we are trying to position ourselves to use the advantages we have to get deals that are attractive to us
Bryan Maher Thank you and good morning
We use the net proceeds from these dispositions to pay down our variable rate debt, resulting in a leverage ratio at the end of the year of 43.6% to position the company for growth as accretive acquisition opportunities arise
Jeffery Busch Good morning
Robert Stevenson Good morning, guys
       

Bearish Statements during earnings call

Statement
In the fourth quarter, our total revenues decreased compared to last year to $33 million
FFO in the fourth quarter was $0.19 per share and unit, down $0.03 from the prior year quarter
And our AFFO was $0.23 per share and unit, down $0.01 from the prior year quarter
Additionally, an unattractive debt refinancing market could push previously reluctant sellers our way as these sellers run out of refinancing options
Bob, revenues were down $2.6 million quarter-over-quarter, operating expenses were down 1.1 and sort of below where it's been over the last few
The big driver for the decrease overall was the disposition activity, number one, but then number two, unique to the fourth quarter was the fact that we put on reserves for $1.1 million, that was a reduction of revenue for the quarter
And so kind of predates the IPO of the company, but it had been causing us a lot of cash management issues as well as administrative issues
Reduction in revenue is primarily driven by our property dispositions completed during the first 9 months of the year, as well as the recognition of reserves for approximately $1.1 million of related to our medical office building tenants in East Orange New Jersey, including approximately $0.2 million of deferred rent
As of December 31, 2023, our gross investment in real estate was $1.4 billion, which is down about $60 million from the start of the year reflecting our disposition activity
Our interest expense in the fourth quarter was $7 million, compared to $8.1 million in the comparable quarter of last year, reflecting the impact of lower average borrowings and lower interest rates compared to the prior year period
As previously mentioned, with our reduced leverage ratio, during the third quarter, we lowered the SOFR margins in our credit facility by 15 basis points
And again, what the CMBS does is limit your ability relative to those assets, even at simple things such as maintenance can be burdensome with the CMBS, or things you want to change with the property can be burdensome with the CMBS
Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond the company's control, including, without limitation, those contained in the company's 10-K for the year ended December 31, 2022, and its other SEC filings
In 2023, we patiently managed through continual difficult market conditions for acquisitions, and look to opportunistically dispose of assets to reduce our leverage and variable rate debt
   

Please consider a small donation if you think this website provides you with relevant information